Abstract: The present application relates to a novel compound, and a pharmaceutical composition for preventing or treating resistant cancer, the composition comprising the novel compound or a pharmaceutically acceptable salt thereof. When a composition according to the present application and an anticancer agent are administered together, an excellent anticancer effect may be exhibited.

Abstract: A server that creates a spatial model includes a derivation unit configured to derive boundary point information from a panoramic image of an indoor space; a point cloud creation unit configured to create a point cloud for the panoramic image; a division unit configured to divide the point cloud based on the boundary point information; a texture image creation unit configured to create a texture image by projecting the divided point cloud onto a plane corresponding to the divided point cloud; a mesh model creation unit configured to extract geometric information from the point cloud based on the boundary point information, and create a mesh model based on the extracted geometric information; and a spatial model creation unit configured to create the spatial model for the indoor space based on the texture image and the mesh model.

Abstract: The present invention relates to a novel compound, a method for preparing same, and a pharmaceutical composition for the prevention or treatment of refractory cancer, comprising the novel compound or a pharmaceutically acceptable salt thereof. When the composition of the present invention and anticancer drug are administered in combination, excellent anticancer effects can be exhibited.

Abstract: The present invention relates to a novel compound and a pharmaceutical composition for enhancing anticancer activity, which includes the same, and more particularly, to a pharmaceutical composition, which includes a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof, thereby enhancing anticancer activity of an anticancer agent or radiation, and inducing proliferation inhibition and death of cancer cells, resulting in effectively treating cancer:

Abstract: A touch screen panel, which may be included in a display device, is capable of removing influence due to static electricity applied from the outside by forming a guard ring pattern at an edge of one surface of a window substrate and by implementing a connection part electrically connected to the guard ring pattern so as to directly contact a bezel supporting the touch screen panel.

Abstract: A display device includes a display module, a driving circuit unit, a window, a first flexible circuit board, and a shielding unit. The driving circuit unit may supply a driving signal to the display module. The window may be positioned on the display module. The first flexible circuit board may have a touch sensor at one end portion thereof, the one end portion being attached to the window. The shielding unit may extend to protrude toward the driving circuit unit from the one end portion of the first flexible circuit board to shield the driving circuit unit.

Abstract: A touch screen panel, which may be included in a display device, is capable of removing influence due to static electricity applied from the outside by forming a guard ring pattern at an edge of one surface of a window substrate and by implementing a connection part electrically connected to the guard ring pattern so as to directly contact a bezel supporting the touch screen panel.

Abstract: A liquid crystal display (“LCD”) for eliminating an afterimage includes a power supply, a gate driver and a discharger. The power supply detects the cutting off of external power voltage and supplies a discharge signal. The gate driver simultaneously supplies a gate driving signal to a plurality of gate lines in response to the discharge signal, and the discharger supplies a common voltage to a plurality of data lines in response to the discharge signal.